Novozymes says Chr. Hansen takeover is in a ‘good spot’ following EU filing
Danish enzyme maker Novozymes told investors today that it was confident it would close its $12.3 billion acquisition of compatriot Chr. Hansen by the end of the year, or early in...To view the full article, register now.
Already a subscriber? Click here to view full article